Publications:

Do Genetic Polymorphisms Affect Fetal Hemoglobin (HbF) Levels in Patients With Sickle Cell Anemia Treated With Hydroxyurea? A Systematic Review and Pathway Analysis.

Frontiers In Pharmacology

Sales, Rahyssa Rodrigues RR; Nogueira, Bárbara Lisboa BL; Tosatti, Jéssica Abdo Gonçalves JAG; Gomes, Karina Braga KB; Luizon, Marcelo Rizzatti MR

Publication Date: 2021

Variant appearance in text: rs172652

PubMed Link: 35126118

Variant Present in the following documents:

• Main text
• fphar-12-779497.pdf

View BVdb publication page

Genome-based therapeutic interventions for β-type hemoglobinopathies.

Human Genomics

Karamperis, Kariofyllis K; Tsoumpeli, Maria T MT; Kounelis, Fotios F; Koromina, Maria M; Mitropoulou, Christina C; Moutinho, Catia C; Patrinos, George P GP

Publication Date: 2021-06-05

Variant appearance in text: rs172652

PubMed Link: 34090531

Variant Present in the following documents:

• Main text
• 40246_2021_Article_329.pdf

View BVdb publication page

An Expert Review of Pharmacogenomics of Sickle Cell Disease Therapeutics: Not Yet Ready for Global Precision Medicine.

Omics : A Journal Of Integrative Biology

Mnika, Khuthala K; Pule, Gift D GD; Dandara, Collet C; Wonkam, Ambroise A

Publication Date: 2016-10

Variant appearance in text: rs172652

PubMed Link: 27636225

Variant Present in the following documents:

• Main text

View BVdb publication page

Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.

Genomics Insights

Driss, A A; Asare, K O KO; Hibbert, J M JM; Gee, B E BE; Adamkiewicz, T V TV; Stiles, J K JK

Publication Date: 2009-07-30

Variant appearance in text: rs172652

PubMed Link: 20401335

Variant Present in the following documents:

• Main text
• gei-2-2009-023.pdf

View BVdb publication page